Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2009-04-13 | Scott Cormack Richmond, Canada 44 Director, President and Chief Executive Officer 2008 |
| 2010-04-19 | Scott Cormack Richmond, Canada 44 Director, President, Chief Executive Officer and Secretary 2008 |
| 2011-04-21 | Scott Cormack, 45, has been our President, Chief Executive Officer and a director since August 2008, and has been our Secretary since February 2010. |
| 2012-04-26 | Scott Cormack, 46, has been our President, Chief Executive Officer and a director since August 2008. |
| 2013-04-22 | Scott Cormack, 47, has been our President, Chief Executive Officer and a director since August 2008. |
| 2014-04-24 | Scott Cormack, 48, has been our President, Chief Executive Officer and a director since August 2008. |
| 2015-04-16 | Scott Cormack Vancouver, Canada 49 Director, President and Chief Executive Officer 2008 |
| 2017-09-21 | Scott Cormack 51 Director 2008 |
| 2018-04-19 | Scott Cormack has been a director since August 2008. Mr. Cormack also served as our President and Chief Executive Officer from August 2008 until the consummation of the merger between OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. in August 2017. |
| 2018-08-16 | Scott Cormack Represents 1,481 shares owned directly, 3,505 options exercisable within 60 days of July 30, 2018, and 968 shares owned indirectly through his spouse. |
| 2019-03-28 | Scott Cormack 54 Director 2008 The following table summarizes all compensation paid to or earned by non-employee directors who served during 2018 as compensation for board service during the 2018 fiscal year. Scott Cormack 40,000 22,149 62,149 |
| 2020-04-02 | Scott Cormack 55 Director 2008 |
Data sourced from SEC filings. Last updated: 2026-02-03